Proceeding of the 13th International SHR Meeting
T. Yamaguchi,T. Izumi,M. Matsumoto,H. Togashi,S. L. Chu,G. L. Wang,S. N. Wu,P. J. Gao,D. L. Zhu,X. O. Zhou,J. Zhao,S. Wu,Y. S. Qian
2008-01-01
Abstract:s are presented in the alphabetical order of the first author names and are printed without editing in the submitted form. The Editorial Office of Physiological Research disclaims any responsibility for errors that may have been made in abstracts submitted by the authors. Proceeding of the 13th International SHR Meeting June 20-22, 2008 Prague, the Czech Republic Vol. 57 Physiol. Res. 2008 37P CLOSING IN ON A MOLECULAR DESCRIPTION OF THE SHR T.J. Aitman MRC Clinical Sciences Centre and Imperial College London, UK Remarkable advances in genomics have occurred in the past 5 years including the advent of whole genome association studies and the ability to re-sequence entire mammalian genomes at a tiny fraction of the cost of the original sequences. The spontaneously hypertensive rat has a distinguished track record as a model of hypertension and metabolic syndrome. Scores of quantitative trait loci (QTLs) have been mapped to discrete regions of the genome over the past two decades and a small number of the underlying molecular defects (quantitative trait nucleotides or QTNs) have been identified. With advances in genome technology and integrative approaches that use expression profiling and informatics, the genome sequence of the SHR is now in our hands, and the opportunity to identify QTNs for large numbers of QTLs presents itself. This talk will address the present state of the art in SHR genomics, and will look to the possibilities for discovery of SHR disease genes and pathways, and their potential translation to human biology, over the next 5 years. PRODUCTION OF GAMMA-AMINOBUTYRIC ACID (GABA)ENRICHED RICE GRAINS AND THEIR HYPOTENSIVE EFFECT BOTH IN SHR/Ncrlcrlj AND SHR/NDmcr-cp/cp K. Akama, J. Kanetou, S. Shimosaki, S. Tsuchikura Department of Biological Science, Shimane University, Matsue, Japan; Department of Experimental Animals, Shimane University, Izumo, Japan; Disease Model Cooperative Research Association, Hamamatsu, Japan Recently, lifestyle-related diseases such as obesity, high blood pressure and hyperlipemia have getting severe problems rest of the world regarding not only human health but also increase in medical expenses. GABA, one of the ubiquitous non-protein amino acids and known to be an inhibitory neurotransmitter, has been focusing due to its effect on blood pressure decrease. GABA itself is synthesized from L-glutamate by glutamate decarboxylase in the cells. Here we report an effect of GABA-enriched rice grains in SHRs. Based upon both molecular approaches of protein engineering and over-expression of a rice GAD gene in the seeds, we have successfully established transgenic rice lines that produce GABA-enriched rice grains: amino acid analysis indicated threeto thirty-fold GABA content increase, compared with those of wild-type. Interestingly, most of the free protein amino acids were also increased in the seeds. GABAenriched rice was administered to ten weeks old of SHR/Ncrlcrlj or eight weeks old of SHR/NDmcr-cp/cp everyday for six weeks (GABA dose of 0.5 mg/kg body weight) and systolic blood pressure was measured. At three, four, and five weeks after administration to two different kinds of SHRs, blood pressure lowering effect was each observed with a statistically significant level compared with the control group. These results suggest that GABA-enriched rice grains developed in this study have a hypotensive effect in SHRs through a long-range action. Transgenic rice grains enriched with free amino acids as well as GABA have a blood pressure lowering effect reproducibly on SHRs. BRAIN DAMAGE IN AN ANIMAL MODEL OF HYPERALDOSTERONISM F. Amenta, D. Tomassoni, B. Toffoli, S. Bernardi, S.K. Tayebati, B. Fabris Department of Experimental Medicine and Public Health, University of Camerino, Camerino, Italy; Department of Clinical Medicine and Neurology, University of Trieste, Trieste, Italy Aldosterone exerts a number of effects in the central nervous system. Facilitated by its lipophilic properties, aldosterone can cross the bloodbrain barrier, and causes acute and long-term effects on brain vascular structures. Aldosterone has been implicated in the pathogenesis of vascular disease and elevated plasma aldosterone is considered as a risk factor for stroke, although mechanism(s) underlying this role remain(s) to be elucidated. The present study was designed to assess possible neuronal, neuroglial and blood-brain-barrier changes induced by aldosterone in an animal model of hyperaldosteronism. Male Wistar rats of 8 weeks of age were treated for 28 days with aldosterone (40 μg/kg/day) via osmotic minipumps with or without 0.9 % NaCl. In control animals, minipumps contained vehicle alone and no salt was added to drinking water. Microanatomical aspects of intracerebral and pial artery, nerve cell number, phosphorylated 200-kDa neurofilament immunoreactivity were assessed by microanatomical, and immunohistochemical techniques. Rats treated with aldosterone alone or plus salt load developed arterial hypertension and displayed microanatomical changes of the vascular tree, nerve cell loss and cytoskeletal breakdown. Neuronal changes occurred primarily in the frontal cortex, striatum and CA1 subfield of hippocampus. These data suggest that aldosterone causes brain injury that can be related with blood pressure rise or with neurotoxicity linked to specific mineralocorticoid receptor activity. Supported by the grant MIUR-COFIN No. 2006060985_003. FUNCTIONAL ANALYSIS OF CARDIOVASCULAR GENES BY TARGETED GENE KNOCKDOWN IN RATS M. Bader Max Delbrück Center for Molecular Medicine (MDC), Berlin-Buch, Germany The rat is the preferred animal model in several areas of research including the study of cardiovascular diseases. However, gene targeting technology is not established for this species due to the lack of germline competent embryonic stem cells. Therefore, our goal was to evaluate different methods to attenuate or ablate expression of a specific gene in transgenic rats. First, we successfully generated a transgenic rat expressing antisense RNA against angiotensinogen exclusively in the brain. These animals showed a 90% reduction in angiotensinogen concentration in the brain with no change in other organs. As a consequence, the rats developed reduced blood pressure, a mild diabetes insipidus and alterations in autonomic control confirming the important function of angiotensin in central cardiovascular control. As a second model we generated transgenic rats expressing a dominant negative mutant of the NPR-B receptor for Ctype natriuretic peptide. These rats spontaneously developed cardiac hypertrophy providing evidence for a central role of this hormone in cardiac growth control. Recently, we used shRNA technology to knockdown genes in rats. We employed a novel tetracycline inducible shRNA expression system targeting the insulin receptor (InsR) and successfully generated shRNA transgenic rats. Doxycycline (DOX) treatment of these animals led to a dose-dependent increase in blood glucose caused by a nearly total inhibition of InsR expression, which was reversible. We could neither detect an interferon response nor any disturbancies in microRNA processing in the transgenic rats under DOX treatment indicating that there are no toxic side effects of the shRNAbased gene suppression. Thus, these rats represent a new model for diabetes mellitus type 2. In conclusion, we have developed novel technologies allowing the specific suppression of genes in the rat. PANEL DISCUSSION: A TRANSGENIC VIEW ON PHYSIOLOGY M. Bader Max-Delbrück-Center for Molecular Medicine, Berlin, Germany When physiologists ask me whether their discipline has a future in the times of -omics, I tell them that it will become even more important. Transgenic researchers such as myself can generate animals with all kinds of alterations in single genes. In a lot of cases the animals survive these handicaps. And then tedious work is necessary to detect the consequences of the genetic alteration, if any. To this purpose, classical 38P Physiol. Res. 2008 Vol. 57 physiology is essential. In particular, system physiology is of greatest importance. Most researchers have a limited focus on a single cell type or organ and analyze their transgenic animal models only with a few established technologies focussing on this tissue. I am sure, hundreds of transgenic lines still bear a secret which would enhance our knowledge about the physiological function of the affected gene. It was not yet uncovered due to an incomplete phenotyping of the animals. Therefore, there are more and more public and commercial labs offering a broad check up of transgenic and knockout mouse lines. And in these labs classical physiology revives. In my lab, we generate animals with alterations in hormone coding genes. If we would not analyze the animals with a multitude of collaboration partners disposing of very divergent expertises in physiology, we would miss the most important phenotypes. For example our mice lacking the enzyme tryptophan hydroxylase 1, which is responsible for serotonin synthesis in the periphery, would have never been comprehensively phenotyped without such partners. We found out that the mice have a defect in hemostasis but our partners discovered functions in the physiology of the mammary gland, the liver, and the pulmonary vasculature. And for sure there are still phenotypes to be discovered in these animals. The most promising and also most important in the respect of this meeting is that the mice are slightly hypertensive. Thus surprisingly, peripheral serotonin exerts a tonic antihypertensive effect. By employing classical systems physiology of cardiovascular regulation we try to clarify the implicated mechanisms in the moment. In conclusion, classical physiology will not die out. In the opposite, it becomes an increasingly indispensable tool in the analysis of genetically altered animal models. CHRONIC CROWDING STRESS PRODUCES NITRIC OXIDE DEFICIENCY AND EN